Display options
Cite
Kawasaki H, Nakano T, Kohdera U, et al. The effect of thrombopoietin on erythroid progenitors in Diamond-Blackfan anemia. Int J Hematol. 2002;75(4):382-4doi: 10.1007/BF02982128.
Kawasaki, H., Nakano, T., Kohdera, U., & Kobayashi, Y. (2002). The effect of thrombopoietin on erythroid progenitors in Diamond-Blackfan anemia. International journal of hematology, 75(4), 382-4. https://doi.org/10.1007/BF02982128
Kawasaki, Hirohide, et al. "The effect of thrombopoietin on erythroid progenitors in Diamond-Blackfan anemia." International journal of hematology vol. 75,4 (2002): 382-4. doi: https://doi.org/10.1007/BF02982128
Kawasaki H, Nakano T, Kohdera U, Kobayashi Y. The effect of thrombopoietin on erythroid progenitors in Diamond-Blackfan anemia. Int J Hematol. 2002 May;75(4):382-4. doi: 10.1007/BF02982128. PMID: 12041668.
Copy Download .nbib Format: NLM
Share it on

Int J Hematol. 2002 May;75(4):382-4. doi: 10.1007/BF02982128.

The effect of thrombopoietin on erythroid progenitors in Diamond-Blackfan anemia.

International journal of hematology

Hirohide Kawasaki, Takahide Nakano, Urara Kohdera, Yohnosuke Kobayashi

Affiliations

  1. Department of Pediatrics, Kansai Medical University, Osaka, Japan. [email protected]

PMID: 12041668 DOI: 10.1007/BF02982128

Abstract

Diamond-Blackfan anemia (DBA) is a rare congenital red blood cell aplasia. Usually, erythropoiesis in vitro is defective, and decreased numbers of erythroid progenitors are found in colony assays performed with bone marrow cells. Recently, some investigators showed that thrombopoietin (TPO) also works on common multipotent progenitor cells and stimulates erythropoiesis. We examined the effect of TPO together with erythropoietin (EPO), stem cell factor (SCF), and/or interleukin-3 (IL-3) on erythroid burst-forming units (BFU-E) of bone marrow nonadherent mononuclear cells from 2 patients with DBA using a serum-free culture system. Very few BFU-E appeared in cultures containing EPO alone. Adding IL-3, SCF, or both to cultures containing EPO induced an increase in the number of BFU-E. When TPO was added to cultures containing EPO and IL-3, SCF, or both, the number of BFU-E further increased. Especially in patient 2, BFU-E formation was grossly equal to that in normal controls. We conclude that TPO enhances bone marrow erythropoiesis in patients with DBA in the presence of EPO and SCF and/or IL-3. The data raise the possibility of the combination of TPO and SCF as a therapeutic agent in DBA.

References

  1. Blood. 1995 Jul 15;86(2):419-31 - PubMed
  2. Blood. 1996 Aug 15;88(4):1284-96 - PubMed
  3. Br J Haematol. 1991 Oct;79(2):316-21 - PubMed
  4. Blood. 1988 Sep;72(3):970-7 - PubMed
  5. Am J Pediatr Hematol Oncol. 1989 Winter;11(4):380-94 - PubMed
  6. Blood. 1992 Dec 15;80(12):3000-8 - PubMed
  7. Blood. 1991 Nov 1;78(9):2198-202 - PubMed
  8. J Clin Invest. 1995 Sep;96(3):1683-7 - PubMed
  9. Exp Hematol. 1996 Apr;24(5):660-9 - PubMed
  10. Blood. 1995 Nov 1;86(9):3308-13 - PubMed
  11. Blood. 1991 Nov 1;78(9):2211-5 - PubMed
  12. Blood. 1989 Apr;73(5):1168-74 - PubMed
  13. Blood. 2000 Apr 15;95(8):2559-68 - PubMed
  14. Br J Haematol. 1996 Sep;94(4):645-53 - PubMed
  15. Blood. 1991 Nov 1;78(9):2203-10 - PubMed
  16. Blood. 1995 Oct 1;86(7):2494-9 - PubMed
  17. Blood. 1993 Aug 1;82(3):744-51 - PubMed
  18. Br J Haematol. 1997 Jul;98(1):8-17 - PubMed
  19. Br J Haematol. 1997 Jun;97(4):871-80 - PubMed
  20. Blood. 1990 Oct 1;76(7):1330-5 - PubMed

Substances

MeSH terms

Publication Types